Ivan Bergstein is CEO at STEMLINE THERAPEUTICS INC (STML). They have made 23 open-market trades across 1 company since 2014, most recently 2020-06-10.
CIK 0001554767
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $22K since 2014, against 22 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| STML | 3,024,336 | $35.8M |
Shares reported on the most recent Form 4, priced at the 2020-06-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| STML | SELL | 2020-04-15 | 2020-04-20 | $4.88 | $523K | +4.0% | +135.6% | N/A |
| STML | SELL | 2020-03-09 | 2020-03-13 | $4.98 | $572K | +5.7% | +24.7% | N/A |
| STML | SELL | 2020-02-25 | 2020-02-28 | $6.42 | $316K | -22.7% | -21.6% | +95.4% |
| STML | SELL | 2019-12-23 | 2020-01-03 | $10.87 | $987K | -35.8% | -36.3% | -56.5% |
| STML | SELL | 2019-08-14 | 2019-08-16 | $14.73 | $1.0M | -21.2% | -29.0% | -38.4% |
| STML | SELL | 2019-06-24 | 2019-06-28 | $15.07 | $1.3M | -10.1% | -15.1% | -31.2% |
| STML | SELL | 2019-03-11 | 2019-03-15 | $11.11 | $1.2M | -7.6% | +7.2% | +7.7% |
| STML | SELL | 2019-03-07 | 2019-03-08 | $11.41 | $78K | +10.6% | +22.4% | +20.4% |
| STML | SELL | 2019-02-25 | 2019-02-27 | $12.03 | $551K | -0.5% | +15.8% | +30.1% |
| STML | SELL | 2019-02-14 | 2019-02-15 | $10.98 | $750K | -4.6% | +12.2% | +27.1% |
| STML | SELL | 2018-03-12 | 2018-03-14 | $17.34 | $1.3M | -6.4% | +6.4% | +10.4% |
| STML | SELL | 2018-03-07 | 2018-03-09 | $16.56 | $225K | -25.1% | -12.4% | -0.5% |
| STML | SELL | 2018-02-26 | 2018-02-28 | $17.42 | $842K | +1.8% | -14.3% | +13.5% |
| STML | SELL | 2018-02-15 | 2018-02-16 | $15.80 | $60K | +6.7% | -10.2% | +24.2% |
| STML | SELL | 2017-03-07 | 2017-03-09 | $8.13 | $44K | -2.2% | -4.5% | -14.6% |
| STML | SELL | 2017-02-27 | 2017-03-01 | $7.00 | $199K | +25.3% | +8.2% | +2.5% |
| STML | SELL | 2017-02-16 | 2017-02-17 | $6.42 | $23K | +15.4% | +34.3% | +18.2% |
| STML | SELL | 2016-03-08 | 2016-03-10 | $5.34 | $30K | -5.8% | -3.8% | +67.5% |
| STML | SELL | 2016-02-17 | 2016-02-19 | $4.46 | $14K | +13.2% | +17.3% | +29.3% |
| STML | SELL | 2015-11-30 | 2015-12-01 | $8.20 | $100K | -23.8% | -2.4% | -22.8% |
| STML | SELL | 2015-02-18 | 2015-02-20 | $14.02 | $45K | -23.8% | -2.4% | -2.4% |
| STML | SELL | 2014-11-26 | 2014-11-26 | $14.40 | $172K | -23.8% | -2.4% | -2.4% |
| STML | BUY | 2014-09-03 | 2014-09-03 | $11.05 | $22K | -23.8% | -2.4% | -2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.